symbol,statement_type,period_end,line_item,value
JUBLPHARMA.NS,cashflow,2025-03-31 00:00:00,Free Cash Flow,-435000000.0
JUBLPHARMA.NS,cashflow,2025-03-31 00:00:00,Repurchase Of Capital Stock,-56000000.0
JUBLPHARMA.NS,cashflow,2025-03-31 00:00:00,Repayment Of Debt,-11004000000.0
JUBLPHARMA.NS,cashflow,2025-03-31 00:00:00,Issuance Of Debt,49000000.0
JUBLPHARMA.NS,cashflow,2025-03-31 00:00:00,Issuance Of Capital Stock,9000000.0
JUBLPHARMA.NS,cashflow,2025-03-31 00:00:00,Capital Expenditure,-11156000000.0
JUBLPHARMA.NS,cashflow,2025-03-31 00:00:00,End Cash Position,10883000000.0
JUBLPHARMA.NS,cashflow,2025-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,
JUBLPHARMA.NS,cashflow,2025-03-31 00:00:00,Beginning Cash Position,9564000000.0
JUBLPHARMA.NS,cashflow,2025-03-31 00:00:00,Effect Of Exchange Rate Changes,248000000.0
JUBLPHARMA.NS,cashflow,2025-03-31 00:00:00,Changes In Cash,1071000000.0
JUBLPHARMA.NS,cashflow,2025-03-31 00:00:00,Financing Cash Flow,-14527000000.0
JUBLPHARMA.NS,cashflow,2025-03-31 00:00:00,Interest Paid Cff,-2356000000.0
JUBLPHARMA.NS,cashflow,2025-03-31 00:00:00,Cash Dividends Paid,-796000000.0
JUBLPHARMA.NS,cashflow,2025-03-31 00:00:00,Common Stock Dividend Paid,-796000000.0
JUBLPHARMA.NS,cashflow,2025-03-31 00:00:00,Net Common Stock Issuance,-47000000.0
JUBLPHARMA.NS,cashflow,2025-03-31 00:00:00,Common Stock Payments,-56000000.0
JUBLPHARMA.NS,cashflow,2025-03-31 00:00:00,Common Stock Issuance,9000000.0
JUBLPHARMA.NS,cashflow,2025-03-31 00:00:00,Net Issuance Payments Of Debt,-10730000000.0
JUBLPHARMA.NS,cashflow,2025-03-31 00:00:00,Net Short Term Debt Issuance,225000000.0
JUBLPHARMA.NS,cashflow,2025-03-31 00:00:00,Net Long Term Debt Issuance,-10955000000.0
JUBLPHARMA.NS,cashflow,2025-03-31 00:00:00,Long Term Debt Payments,-11004000000.0
JUBLPHARMA.NS,cashflow,2025-03-31 00:00:00,Long Term Debt Issuance,49000000.0
JUBLPHARMA.NS,cashflow,2025-03-31 00:00:00,Investing Cash Flow,4877000000.0
JUBLPHARMA.NS,cashflow,2025-03-31 00:00:00,Net Other Investing Changes,6092000000.0
JUBLPHARMA.NS,cashflow,2025-03-31 00:00:00,Interest Received Cfi,384000000.0
JUBLPHARMA.NS,cashflow,2025-03-31 00:00:00,Dividends Received Cfi,0.0
JUBLPHARMA.NS,cashflow,2025-03-31 00:00:00,Net Investment Purchase And Sale,9507000000.0
JUBLPHARMA.NS,cashflow,2025-03-31 00:00:00,Sale Of Investment,9521000000.0
JUBLPHARMA.NS,cashflow,2025-03-31 00:00:00,Purchase Of Investment,-14000000.0
JUBLPHARMA.NS,cashflow,2025-03-31 00:00:00,Net PPE Purchase And Sale,-11106000000.0
JUBLPHARMA.NS,cashflow,2025-03-31 00:00:00,Sale Of PPE,50000000.0
JUBLPHARMA.NS,cashflow,2025-03-31 00:00:00,Purchase Of PPE,-11156000000.0
JUBLPHARMA.NS,cashflow,2025-03-31 00:00:00,Operating Cash Flow,10721000000.0
JUBLPHARMA.NS,cashflow,2025-03-31 00:00:00,Taxes Refund Paid,-2384000000.0
JUBLPHARMA.NS,cashflow,2025-03-31 00:00:00,Change In Working Capital,1118000000.0
JUBLPHARMA.NS,cashflow,2025-03-31 00:00:00,Change In Other Current Liabilities,-170000000.0
JUBLPHARMA.NS,cashflow,2025-03-31 00:00:00,Change In Payable,553000000.0
JUBLPHARMA.NS,cashflow,2025-03-31 00:00:00,Change In Inventory,785000000.0
JUBLPHARMA.NS,cashflow,2025-03-31 00:00:00,Change In Receivables,-50000000.0
JUBLPHARMA.NS,cashflow,2025-03-31 00:00:00,Other Non Cash Items,-1558000000.0
JUBLPHARMA.NS,cashflow,2025-03-31 00:00:00,Stock Based Compensation,43000000.0
JUBLPHARMA.NS,cashflow,2025-03-31 00:00:00,Depreciation And Amortization,3686000000.0
JUBLPHARMA.NS,cashflow,2025-03-31 00:00:00,Amortization Cash Flow,
JUBLPHARMA.NS,cashflow,2025-03-31 00:00:00,Depreciation,3686000000.0
JUBLPHARMA.NS,cashflow,2025-03-31 00:00:00,Gain Loss On Investment Securities,17000000.0
JUBLPHARMA.NS,cashflow,2025-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,1000000.0
JUBLPHARMA.NS,cashflow,2025-03-31 00:00:00,Gain Loss On Sale Of PPE,-13000000.0
JUBLPHARMA.NS,cashflow,2025-03-31 00:00:00,Net Income From Continuing Operations,9806000000.0
JUBLPHARMA.NS,cashflow,2024-03-31 00:00:00,Free Cash Flow,736000000.0
JUBLPHARMA.NS,cashflow,2024-03-31 00:00:00,Repurchase Of Capital Stock,-274000000.0
JUBLPHARMA.NS,cashflow,2024-03-31 00:00:00,Repayment Of Debt,-759000000.0
JUBLPHARMA.NS,cashflow,2024-03-31 00:00:00,Issuance Of Debt,1172000000.0
JUBLPHARMA.NS,cashflow,2024-03-31 00:00:00,Issuance Of Capital Stock,0.0
JUBLPHARMA.NS,cashflow,2024-03-31 00:00:00,Capital Expenditure,-8977000000.0
JUBLPHARMA.NS,cashflow,2024-03-31 00:00:00,End Cash Position,9564000000.0
JUBLPHARMA.NS,cashflow,2024-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,
JUBLPHARMA.NS,cashflow,2024-03-31 00:00:00,Beginning Cash Position,10139000000.0
JUBLPHARMA.NS,cashflow,2024-03-31 00:00:00,Effect Of Exchange Rate Changes,116000000.0
JUBLPHARMA.NS,cashflow,2024-03-31 00:00:00,Changes In Cash,-691000000.0
JUBLPHARMA.NS,cashflow,2024-03-31 00:00:00,Financing Cash Flow,-4325000000.0
JUBLPHARMA.NS,cashflow,2024-03-31 00:00:00,Interest Paid Cff,-2437000000.0
JUBLPHARMA.NS,cashflow,2024-03-31 00:00:00,Cash Dividends Paid,-798000000.0
JUBLPHARMA.NS,cashflow,2024-03-31 00:00:00,Common Stock Dividend Paid,-798000000.0
JUBLPHARMA.NS,cashflow,2024-03-31 00:00:00,Net Common Stock Issuance,-274000000.0
JUBLPHARMA.NS,cashflow,2024-03-31 00:00:00,Common Stock Payments,-274000000.0
JUBLPHARMA.NS,cashflow,2024-03-31 00:00:00,Common Stock Issuance,0.0
JUBLPHARMA.NS,cashflow,2024-03-31 00:00:00,Net Issuance Payments Of Debt,-204000000.0
JUBLPHARMA.NS,cashflow,2024-03-31 00:00:00,Net Short Term Debt Issuance,-617000000.0
JUBLPHARMA.NS,cashflow,2024-03-31 00:00:00,Net Long Term Debt Issuance,413000000.0
JUBLPHARMA.NS,cashflow,2024-03-31 00:00:00,Long Term Debt Payments,-759000000.0
JUBLPHARMA.NS,cashflow,2024-03-31 00:00:00,Long Term Debt Issuance,1172000000.0
JUBLPHARMA.NS,cashflow,2024-03-31 00:00:00,Investing Cash Flow,-6079000000.0
JUBLPHARMA.NS,cashflow,2024-03-31 00:00:00,Net Other Investing Changes,2297000000.0
JUBLPHARMA.NS,cashflow,2024-03-31 00:00:00,Interest Received Cfi,257000000.0
JUBLPHARMA.NS,cashflow,2024-03-31 00:00:00,Dividends Received Cfi,268000000.0
JUBLPHARMA.NS,cashflow,2024-03-31 00:00:00,Net Investment Purchase And Sale,-21000000.0
JUBLPHARMA.NS,cashflow,2024-03-31 00:00:00,Sale Of Investment,57000000.0
JUBLPHARMA.NS,cashflow,2024-03-31 00:00:00,Purchase Of Investment,-78000000.0
JUBLPHARMA.NS,cashflow,2024-03-31 00:00:00,Net PPE Purchase And Sale,-8880000000.0
JUBLPHARMA.NS,cashflow,2024-03-31 00:00:00,Sale Of PPE,97000000.0
JUBLPHARMA.NS,cashflow,2024-03-31 00:00:00,Purchase Of PPE,-8977000000.0
JUBLPHARMA.NS,cashflow,2024-03-31 00:00:00,Operating Cash Flow,9713000000.0
JUBLPHARMA.NS,cashflow,2024-03-31 00:00:00,Taxes Refund Paid,-2077000000.0
JUBLPHARMA.NS,cashflow,2024-03-31 00:00:00,Change In Working Capital,2531000000.0
JUBLPHARMA.NS,cashflow,2024-03-31 00:00:00,Change In Other Current Liabilities,329000000.0
JUBLPHARMA.NS,cashflow,2024-03-31 00:00:00,Change In Payable,232000000.0
JUBLPHARMA.NS,cashflow,2024-03-31 00:00:00,Change In Inventory,908000000.0
JUBLPHARMA.NS,cashflow,2024-03-31 00:00:00,Change In Receivables,1062000000.0
JUBLPHARMA.NS,cashflow,2024-03-31 00:00:00,Other Non Cash Items,4151000000.0
JUBLPHARMA.NS,cashflow,2024-03-31 00:00:00,Stock Based Compensation,85000000.0
JUBLPHARMA.NS,cashflow,2024-03-31 00:00:00,Depreciation And Amortization,3819000000.0
JUBLPHARMA.NS,cashflow,2024-03-31 00:00:00,Amortization Cash Flow,521000000.0
JUBLPHARMA.NS,cashflow,2024-03-31 00:00:00,Depreciation,3819000000.0
JUBLPHARMA.NS,cashflow,2024-03-31 00:00:00,Gain Loss On Investment Securities,-2000000.0
JUBLPHARMA.NS,cashflow,2024-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,14000000.0
JUBLPHARMA.NS,cashflow,2024-03-31 00:00:00,Gain Loss On Sale Of PPE,-2000000.0
JUBLPHARMA.NS,cashflow,2024-03-31 00:00:00,Net Income From Continuing Operations,1705000000.0
JUBLPHARMA.NS,cashflow,2023-03-31 00:00:00,Free Cash Flow,-1538000000.0
JUBLPHARMA.NS,cashflow,2023-03-31 00:00:00,Repurchase Of Capital Stock,-40000000.0
JUBLPHARMA.NS,cashflow,2023-03-31 00:00:00,Repayment Of Debt,-27730000000.0
JUBLPHARMA.NS,cashflow,2023-03-31 00:00:00,Issuance Of Debt,28104000000.0
JUBLPHARMA.NS,cashflow,2023-03-31 00:00:00,Issuance Of Capital Stock,
JUBLPHARMA.NS,cashflow,2023-03-31 00:00:00,Capital Expenditure,-8145000000.0
JUBLPHARMA.NS,cashflow,2023-03-31 00:00:00,End Cash Position,10139000000.0
JUBLPHARMA.NS,cashflow,2023-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,
JUBLPHARMA.NS,cashflow,2023-03-31 00:00:00,Beginning Cash Position,9838000000.0
JUBLPHARMA.NS,cashflow,2023-03-31 00:00:00,Effect Of Exchange Rate Changes,705000000.0
JUBLPHARMA.NS,cashflow,2023-03-31 00:00:00,Changes In Cash,-404000000.0
JUBLPHARMA.NS,cashflow,2023-03-31 00:00:00,Financing Cash Flow,-1567000000.0
JUBLPHARMA.NS,cashflow,2023-03-31 00:00:00,Interest Paid Cff,-2342000000.0
JUBLPHARMA.NS,cashflow,2023-03-31 00:00:00,Cash Dividends Paid,-801000000.0
JUBLPHARMA.NS,cashflow,2023-03-31 00:00:00,Common Stock Dividend Paid,-801000000.0
JUBLPHARMA.NS,cashflow,2023-03-31 00:00:00,Net Common Stock Issuance,-40000000.0
JUBLPHARMA.NS,cashflow,2023-03-31 00:00:00,Common Stock Payments,-40000000.0
JUBLPHARMA.NS,cashflow,2023-03-31 00:00:00,Common Stock Issuance,
JUBLPHARMA.NS,cashflow,2023-03-31 00:00:00,Net Issuance Payments Of Debt,2317000000.0
JUBLPHARMA.NS,cashflow,2023-03-31 00:00:00,Net Short Term Debt Issuance,1943000000.0
JUBLPHARMA.NS,cashflow,2023-03-31 00:00:00,Net Long Term Debt Issuance,374000000.0
JUBLPHARMA.NS,cashflow,2023-03-31 00:00:00,Long Term Debt Payments,-27730000000.0
JUBLPHARMA.NS,cashflow,2023-03-31 00:00:00,Long Term Debt Issuance,28104000000.0
JUBLPHARMA.NS,cashflow,2023-03-31 00:00:00,Investing Cash Flow,-5444000000.0
JUBLPHARMA.NS,cashflow,2023-03-31 00:00:00,Net Other Investing Changes,2445000000.0
JUBLPHARMA.NS,cashflow,2023-03-31 00:00:00,Interest Received Cfi,100000000.0
JUBLPHARMA.NS,cashflow,2023-03-31 00:00:00,Dividends Received Cfi,88000000.0
JUBLPHARMA.NS,cashflow,2023-03-31 00:00:00,Net Investment Purchase And Sale,-118000000.0
JUBLPHARMA.NS,cashflow,2023-03-31 00:00:00,Sale Of Investment,9000000.0
JUBLPHARMA.NS,cashflow,2023-03-31 00:00:00,Purchase Of Investment,-127000000.0
JUBLPHARMA.NS,cashflow,2023-03-31 00:00:00,Net PPE Purchase And Sale,-7959000000.0
JUBLPHARMA.NS,cashflow,2023-03-31 00:00:00,Sale Of PPE,186000000.0
JUBLPHARMA.NS,cashflow,2023-03-31 00:00:00,Purchase Of PPE,-8145000000.0
JUBLPHARMA.NS,cashflow,2023-03-31 00:00:00,Operating Cash Flow,6607000000.0
JUBLPHARMA.NS,cashflow,2023-03-31 00:00:00,Taxes Refund Paid,-2043000000.0
JUBLPHARMA.NS,cashflow,2023-03-31 00:00:00,Change In Working Capital,543000000.0
JUBLPHARMA.NS,cashflow,2023-03-31 00:00:00,Change In Other Current Liabilities,-2742000000.0
JUBLPHARMA.NS,cashflow,2023-03-31 00:00:00,Change In Payable,2105000000.0
JUBLPHARMA.NS,cashflow,2023-03-31 00:00:00,Change In Inventory,-647000000.0
JUBLPHARMA.NS,cashflow,2023-03-31 00:00:00,Change In Receivables,1827000000.0
JUBLPHARMA.NS,cashflow,2023-03-31 00:00:00,Other Non Cash Items,2352000000.0
JUBLPHARMA.NS,cashflow,2023-03-31 00:00:00,Stock Based Compensation,37000000.0
JUBLPHARMA.NS,cashflow,2023-03-31 00:00:00,Depreciation And Amortization,5540000000.0
JUBLPHARMA.NS,cashflow,2023-03-31 00:00:00,Amortization Cash Flow,2379000000.0
JUBLPHARMA.NS,cashflow,2023-03-31 00:00:00,Depreciation,3161000000.0
JUBLPHARMA.NS,cashflow,2023-03-31 00:00:00,Gain Loss On Investment Securities,50000000.0
JUBLPHARMA.NS,cashflow,2023-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,-54000000.0
JUBLPHARMA.NS,cashflow,2023-03-31 00:00:00,Gain Loss On Sale Of PPE,27000000.0
JUBLPHARMA.NS,cashflow,2023-03-31 00:00:00,Net Income From Continuing Operations,278000000.0
JUBLPHARMA.NS,cashflow,2022-03-31 00:00:00,Free Cash Flow,2375520000.0
JUBLPHARMA.NS,cashflow,2022-03-31 00:00:00,Repurchase Of Capital Stock,0.0
JUBLPHARMA.NS,cashflow,2022-03-31 00:00:00,Repayment Of Debt,-49960000.0
JUBLPHARMA.NS,cashflow,2022-03-31 00:00:00,Issuance Of Debt,2031770000.0
JUBLPHARMA.NS,cashflow,2022-03-31 00:00:00,Issuance Of Capital Stock,0.0
JUBLPHARMA.NS,cashflow,2022-03-31 00:00:00,Capital Expenditure,-5999910000.0
JUBLPHARMA.NS,cashflow,2022-03-31 00:00:00,End Cash Position,9838190000.0
JUBLPHARMA.NS,cashflow,2022-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,
JUBLPHARMA.NS,cashflow,2022-03-31 00:00:00,Beginning Cash Position,5019570000.0
JUBLPHARMA.NS,cashflow,2022-03-31 00:00:00,Effect Of Exchange Rate Changes,572880000.0
JUBLPHARMA.NS,cashflow,2022-03-31 00:00:00,Changes In Cash,4245740000.0
JUBLPHARMA.NS,cashflow,2022-03-31 00:00:00,Financing Cash Flow,-325990000.0
JUBLPHARMA.NS,cashflow,2022-03-31 00:00:00,Interest Paid Cff,-1349370000.0
JUBLPHARMA.NS,cashflow,2022-03-31 00:00:00,Cash Dividends Paid,-800530000.0
JUBLPHARMA.NS,cashflow,2022-03-31 00:00:00,Common Stock Dividend Paid,-800530000.0
JUBLPHARMA.NS,cashflow,2022-03-31 00:00:00,Net Common Stock Issuance,0.0
JUBLPHARMA.NS,cashflow,2022-03-31 00:00:00,Common Stock Payments,0.0
JUBLPHARMA.NS,cashflow,2022-03-31 00:00:00,Common Stock Issuance,0.0
JUBLPHARMA.NS,cashflow,2022-03-31 00:00:00,Net Issuance Payments Of Debt,2421800000.0
JUBLPHARMA.NS,cashflow,2022-03-31 00:00:00,Net Short Term Debt Issuance,439990000.0
JUBLPHARMA.NS,cashflow,2022-03-31 00:00:00,Net Long Term Debt Issuance,1981810000.0
JUBLPHARMA.NS,cashflow,2022-03-31 00:00:00,Long Term Debt Payments,-49960000.0
JUBLPHARMA.NS,cashflow,2022-03-31 00:00:00,Long Term Debt Issuance,2031770000.0
JUBLPHARMA.NS,cashflow,2022-03-31 00:00:00,Investing Cash Flow,-3803700000.0
JUBLPHARMA.NS,cashflow,2022-03-31 00:00:00,Net Other Investing Changes,1702900000.0
JUBLPHARMA.NS,cashflow,2022-03-31 00:00:00,Interest Received Cfi,40210000.0
JUBLPHARMA.NS,cashflow,2022-03-31 00:00:00,Dividends Received Cfi,0.0
JUBLPHARMA.NS,cashflow,2022-03-31 00:00:00,Net Investment Purchase And Sale,2120820000.0
JUBLPHARMA.NS,cashflow,2022-03-31 00:00:00,Sale Of Investment,2144010000.0
JUBLPHARMA.NS,cashflow,2022-03-31 00:00:00,Purchase Of Investment,-23190000.0
JUBLPHARMA.NS,cashflow,2022-03-31 00:00:00,Net PPE Purchase And Sale,-5964730000.0
JUBLPHARMA.NS,cashflow,2022-03-31 00:00:00,Sale Of PPE,35180000.0
JUBLPHARMA.NS,cashflow,2022-03-31 00:00:00,Purchase Of PPE,-5999910000.0
JUBLPHARMA.NS,cashflow,2022-03-31 00:00:00,Operating Cash Flow,8375430000.0
JUBLPHARMA.NS,cashflow,2022-03-31 00:00:00,Taxes Refund Paid,-1940910000.0
JUBLPHARMA.NS,cashflow,2022-03-31 00:00:00,Change In Working Capital,-1782870000.0
JUBLPHARMA.NS,cashflow,2022-03-31 00:00:00,Change In Other Current Liabilities,-428720000.0
JUBLPHARMA.NS,cashflow,2022-03-31 00:00:00,Change In Payable,1580000.0
JUBLPHARMA.NS,cashflow,2022-03-31 00:00:00,Change In Inventory,-956470000.0
JUBLPHARMA.NS,cashflow,2022-03-31 00:00:00,Change In Receivables,-399260000.0
JUBLPHARMA.NS,cashflow,2022-03-31 00:00:00,Other Non Cash Items,1430350000.0
JUBLPHARMA.NS,cashflow,2022-03-31 00:00:00,Stock Based Compensation,11240000.0
JUBLPHARMA.NS,cashflow,2022-03-31 00:00:00,Depreciation And Amortization,3817040000.0
JUBLPHARMA.NS,cashflow,2022-03-31 00:00:00,Amortization Cash Flow,895470000.0
JUBLPHARMA.NS,cashflow,2022-03-31 00:00:00,Depreciation,2921570000.0
JUBLPHARMA.NS,cashflow,2022-03-31 00:00:00,Gain Loss On Investment Securities,-1470000.0
JUBLPHARMA.NS,cashflow,2022-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,404050000.0
JUBLPHARMA.NS,cashflow,2022-03-31 00:00:00,Gain Loss On Sale Of PPE,33700000.0
JUBLPHARMA.NS,cashflow,2022-03-31 00:00:00,Net Income From Continuing Operations,6304470000.0
JUBLPHARMA.NS,cashflow,2021-03-31 00:00:00,Free Cash Flow,
JUBLPHARMA.NS,cashflow,2021-03-31 00:00:00,Repurchase Of Capital Stock,
JUBLPHARMA.NS,cashflow,2021-03-31 00:00:00,Repayment Of Debt,
JUBLPHARMA.NS,cashflow,2021-03-31 00:00:00,Issuance Of Debt,
JUBLPHARMA.NS,cashflow,2021-03-31 00:00:00,Issuance Of Capital Stock,-100610000.0
JUBLPHARMA.NS,cashflow,2021-03-31 00:00:00,Capital Expenditure,
JUBLPHARMA.NS,cashflow,2021-03-31 00:00:00,End Cash Position,
JUBLPHARMA.NS,cashflow,2021-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,-769810000.0
JUBLPHARMA.NS,cashflow,2021-03-31 00:00:00,Beginning Cash Position,
JUBLPHARMA.NS,cashflow,2021-03-31 00:00:00,Effect Of Exchange Rate Changes,
JUBLPHARMA.NS,cashflow,2021-03-31 00:00:00,Changes In Cash,
JUBLPHARMA.NS,cashflow,2021-03-31 00:00:00,Financing Cash Flow,
JUBLPHARMA.NS,cashflow,2021-03-31 00:00:00,Interest Paid Cff,
JUBLPHARMA.NS,cashflow,2021-03-31 00:00:00,Cash Dividends Paid,
JUBLPHARMA.NS,cashflow,2021-03-31 00:00:00,Common Stock Dividend Paid,
JUBLPHARMA.NS,cashflow,2021-03-31 00:00:00,Net Common Stock Issuance,
JUBLPHARMA.NS,cashflow,2021-03-31 00:00:00,Common Stock Payments,
JUBLPHARMA.NS,cashflow,2021-03-31 00:00:00,Common Stock Issuance,-100610000.0
JUBLPHARMA.NS,cashflow,2021-03-31 00:00:00,Net Issuance Payments Of Debt,
JUBLPHARMA.NS,cashflow,2021-03-31 00:00:00,Net Short Term Debt Issuance,
JUBLPHARMA.NS,cashflow,2021-03-31 00:00:00,Net Long Term Debt Issuance,
JUBLPHARMA.NS,cashflow,2021-03-31 00:00:00,Long Term Debt Payments,
JUBLPHARMA.NS,cashflow,2021-03-31 00:00:00,Long Term Debt Issuance,
JUBLPHARMA.NS,cashflow,2021-03-31 00:00:00,Investing Cash Flow,
JUBLPHARMA.NS,cashflow,2021-03-31 00:00:00,Net Other Investing Changes,
JUBLPHARMA.NS,cashflow,2021-03-31 00:00:00,Interest Received Cfi,
JUBLPHARMA.NS,cashflow,2021-03-31 00:00:00,Dividends Received Cfi,
JUBLPHARMA.NS,cashflow,2021-03-31 00:00:00,Net Investment Purchase And Sale,
JUBLPHARMA.NS,cashflow,2021-03-31 00:00:00,Sale Of Investment,
JUBLPHARMA.NS,cashflow,2021-03-31 00:00:00,Purchase Of Investment,
JUBLPHARMA.NS,cashflow,2021-03-31 00:00:00,Net PPE Purchase And Sale,
JUBLPHARMA.NS,cashflow,2021-03-31 00:00:00,Sale Of PPE,
JUBLPHARMA.NS,cashflow,2021-03-31 00:00:00,Purchase Of PPE,
JUBLPHARMA.NS,cashflow,2021-03-31 00:00:00,Operating Cash Flow,
JUBLPHARMA.NS,cashflow,2021-03-31 00:00:00,Taxes Refund Paid,
JUBLPHARMA.NS,cashflow,2021-03-31 00:00:00,Change In Working Capital,
JUBLPHARMA.NS,cashflow,2021-03-31 00:00:00,Change In Other Current Liabilities,
JUBLPHARMA.NS,cashflow,2021-03-31 00:00:00,Change In Payable,
JUBLPHARMA.NS,cashflow,2021-03-31 00:00:00,Change In Inventory,
JUBLPHARMA.NS,cashflow,2021-03-31 00:00:00,Change In Receivables,
JUBLPHARMA.NS,cashflow,2021-03-31 00:00:00,Other Non Cash Items,
JUBLPHARMA.NS,cashflow,2021-03-31 00:00:00,Stock Based Compensation,
JUBLPHARMA.NS,cashflow,2021-03-31 00:00:00,Depreciation And Amortization,
JUBLPHARMA.NS,cashflow,2021-03-31 00:00:00,Amortization Cash Flow,884970000.0
JUBLPHARMA.NS,cashflow,2021-03-31 00:00:00,Depreciation,
JUBLPHARMA.NS,cashflow,2021-03-31 00:00:00,Gain Loss On Investment Securities,
JUBLPHARMA.NS,cashflow,2021-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,
JUBLPHARMA.NS,cashflow,2021-03-31 00:00:00,Gain Loss On Sale Of PPE,
JUBLPHARMA.NS,cashflow,2021-03-31 00:00:00,Net Income From Continuing Operations,
